<DOC>
	<DOCNO>NCT00511797</DOCNO>
	<brief_summary>The purpose study investigate efficacy drospirenone dysmenorrhea .</brief_summary>
	<brief_title>SH T00186 Phase II/ III Optimal Drospirenone ( DRSP ) Dose Finding Placebo-controlled Comparative Study</brief_title>
	<detailed_description />
	<mesh_term>Dysmenorrhea</mesh_term>
	<mesh_term>Drospirenone</mesh_term>
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<criteria>Patients age 20 year old obtain informed consent Patients normal menstrual cycle ( 28+/3 day ) late two menses final enrollment Patients total dysmenorrhea score least 3 point two menstrual cycle final enrollment Patients ovarian chocolate cyst symptomatic uterine fibroid ( define great detail study protocol ) Patients estrogendependent tumor ( e.g . breast cancer , cancer uterine body breast fibrocystic , etc . ) , patient cervical cancer suspect cervical cancer ( e.g . class III great cervical smear endometrial smear examination . ) Patients undiagnosed abnormal vaginal bleeding Patients thrombophlebitis , pulmonary embolism , cerebrovascular disease ( include transient ischemic attack , etc . ) , coronary artery disease ( e.g . myocardial infarction angina pectoris , etc . ) , history disease Patients age 35 year old smoke least 15 cigarette per day Patients migraine accompany prodrome ( e.g . scintillate scotoma starshaped scintillation ) Patients pulmonary hypertension valvular heart disease complicate atrial fibrillation , patient history subacute bacterial endocarditis Patients regularly take nutritional product contain St. John 's Wort Patients underwent surgical treatment endometriosis laparotomy , laparoscopy within 2 month prior screen Patients need use analgesic regularly therapeutic objective relief pain dysmenorrhea study ( occasional use permit )</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Dysmenorrhea</keyword>
	<keyword>Dysmenorrheal score</keyword>
	<keyword>Drospirenone</keyword>
	<keyword>DRSP</keyword>
	<keyword>Ethinylestradiol</keyword>
</DOC>